Showing results (31-40 of 1,341) with videos related to
Sort By:
Pageof 135
Revue Medicale De Liege|April 19, 2019
[Focus on empagliflozin : post hoc analyses of the cardiovascular outcome trial EMPA-REG OUTCOME]A J ScheenRevue Medicale De Liege|March 24, 2015
[How I treat...The choice between a sulphonylulrea and a gliptin to manage hyperglycaemia in type 2 diabetes]A J ScheenRevue Medicale De Liege|March 24, 2015
[Canagliflozin (Invokana): kidney SGLT2 cotransporter inhibitor for treating type 2 diabetes]A J ScheenDiabetes & Metabolism|August 5, 2020
Metformin and COVID-19: From cellular mechanisms to reduced mortalityA J ScheenRevue Medicale De Liege|June 23, 2006
[How I explore...outcomes in clinical trials: comments about recent studies of cardiovascular prevention]A J ScheenRevue Medicale De Liege|December 31, 2008
[Drug selection guided by known and newly diagnosed comorbidities in a multi-risk patient]A J ScheenRevue Medicale De Liege|September 10, 2020
[Ertugliflozin alone and in fixed-dose combinations : «pass of three»]A J ScheenRevue Medicale De Liege|June 22, 2018
[From atherosclerosis to atherothrombosis : from a silent chronic pathology to an acute critical event]A J ScheenRevue Medicale De Liege|June 26, 1998
[Drug clinics. The drug of the month. Alendronate (Fosamax)]A J ScheenPageof 135